Anti-cancer fusion polypeptide
US-2021198380-A1 · Jul 1, 2021 · US
This page is not indexed by search engines while we improve data quality.
Moebius Ulrich patents
Moebius Ulrich is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Moebius Ulrich |
| Total patents | 4 |
| First publication | Feb 16, 2016 |
| Latest publication | Jul 1, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-cancer fusion polypeptide
US-10865250-B2 · Dec 15, 2020 · US
Anti-cancer fusion polypeptide
US-2019010248-A1 · Jan 10, 2019 · US
Treatment of tumors using specific anti-L1 antibody
US-9260521-B2 · Feb 16, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pieris Pharmaceuticals Gmbh | 3 |
| Deutsches Krebsforsch | 2 |
| Medigene Ag | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/73 | 4 |
| A61K2039/505 | 4 |
| A61P35/00 | 4 |
| C07K2317/92 | 4 |
| C07K2319/70 | 3 |